Results 61 to 70 of about 54,096 (328)
Thrombotic and hemorrhagic complications in idiopathic erythrocytosis [PDF]
, 2017 We report clinical features of a large cohort of patients with IE compared to a cohort of patients with PV, focusing on the thrombotic and hemorrhagic ...
Bertozzi, Irene +5 more
core +1 more source
Frontiers in Oncology, 2022 Herein, we report the first case presentation of paraneoplastic myelofibrosis associated with cancer. Paraneoplastic syndromes occur in some patients with thoracic malignancies; however, myelofibrosis is not commonly seen in non-small cell lung cancer ...
Lindsey Sloan +6 more
doaj +1 more source
Derived Langlands VII: The PSH Algebra of Products of General Linear Groups [PDF]
arXiv, 2022 In this article we put a very elaborate PSH-like structure on the $R_{+}(-)$ groups of products of finite general linear groups. This is not the case we want. Firstly one would really want the actual big PSH algebra of products of general linear groups with entries in a characteristic zero $p$-adic local field.
arxiv
American journal of hematology/oncology, 2020 Fedratinib is an oral, selective Janus kinase 2 (JAK2) inhibitor. The phase II JAKARTA2 study assessed fedratinib in patients with intermediate‐ or high‐risk myelofibrosis (MF) who were resistant or intolerant to prior ruxolitinib per investigator ...
C. Harrison +15 more
semanticscholar +1 more source
Budd-Chiari syndrome recurring in a transplanted liver [PDF]
, 1983 A patient with Budd-Chiari syndrome who underwent orthotopic liver transplantation and developed recurrent disease is described. The immediate postoperative period was complicated by multiple thrombotic episodes, followed by a period of apparent ...
Andrew Dekker +11 more
core +1 more source
Сибирский научный медицинский журнал, 2019 The aim of the study was to study the relationship between the qualitative and quantitative characteristics of myelofibrosis and the clinical manifestations of chronic myeloid leukemia and chronic lymphocytic leukemia. Material and methods.
T. Y. Dolgikh +3 more
doaj +1 more source
Targeted Therapy of Myelofibrosis [PDF]
Клиническая онкогематология, 2017 Background. Myelofibrosis (primary myelofibrosis, post-essential trombocythemia myelofibrosis, post-polycythemia myelofibrosis) is the most complex and pressing problem among all Ph-negative myeloproliferative diseases. The present article summarizes the
OYu Vinogradova +10 more
doaj +1 more source
Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
Haematologica, 2021 Thrombocytopenia is common in patients with myelofibrosis (MF) and is a well-established adverse prognostic factor. Both of the approved Janus kinase (JAK) inhibitors, ruxolitinib and fedratinib, can worsen thrombocytopenia and have not been evaluated in
S. Verstovsek +12 more
semanticscholar +1 more source
Differential Diagnoses of Systemic Mastocytosis in Routinely Processed Bone Marrow Biopsy Specimens: A Review [PDF]
, 2010 Diagnosis of systemic mastocytosis (SM) is mainly based on the morphological demonstration of compact mast cell infiltrates in various tissue sites. In almost all patients such infiltrates are detected in the bone marrow.
Horny, H. -P., Sotlar, K., Valent, P.
core +1 more source
Abdominal Ultrasonography in Myelofibrosis [PDF]
Acta Radiologica, 1992 The findings at abdominal ultrasonography (US) in 40 patients with myelofibrosis were reviewed, 20 patients being examined at initial diagnosis and 31 at later stages. Splenomegaly was found in 80% at initial diagnosis and in 97% at later stages. The spleen of 2 patients appeared homogeneously hypoechoic and inhomogeneous in one. Focal splenic lesions
T. Siniluoto +4 more
openaire +3 more sources